Nuo Therapeutics, Inc. (CMXI) Return on Investment ROI from the second quarter of 2026 to second quarter of 2020 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Sep 30 2020 - CSIMarket
CSIMarket
 


Nuo Therapeutics, Inc.  (CMXI)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Nuo Therapeutics,'s ROI from its second quarter of 2026 to the second quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nuo Therapeutics,'s ROI in the second quarter of 2026?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Nuo Therapeutics, Inc.'s return on investment (ROI) in its second quarter of 2026

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1 -1 -1 -1 -1
Return On Investment (TTM) 459.17 % - - - -
CMXI's Overall Ranking # 3887 # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -1 0 0 0 0




Return On Investment CMXI's Ranking
Within: No.
Industry # 8
Sector # 126
Overall # 3887

Return On Investment Statistics
High Average Low
-41.19 %
-49.38 %
-62.57 %
(Jun 30 2013)   (Jun 30 2014)







Financial Statements
Nuo Therapeutics,'s II. Quarter Investments $ 1 Millions CMXI's Balance sheet
Nuo Therapeutics,'s II. Quarter Income $ 0 Millions Quarterly CMXI's Income Statement
CMXI's Income by Division See CMXI's Income by Division


CMXI Annual Return On Investment (Dec 31 2013)
2013
(Dec 31 2012)
2012
(Dec 31 2011)
2011


Total Investments in Millions 36 42 7 0 0
Y / Y Investment Growth -14.03 % 498.21 % - - -
Net Income in Millions -20 -18 -4 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -56.73 % -44.07 % -55.44 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CMXI's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CMXI's Competitors
Subscribers only: Roi for Nuo Therapeutics,'s Suppliers
Subscribers only: Return On Investment for CMXI's Customers

Other Ratios
CMXI's Roa CMXI's Inventory Turnover Ratio CMXI's Growth Rates CMXI's Dividend Statistics
CMXI's Profitability Ratios CMXI's Asset Turnover Ratio CMXI's Dividend Growth
CMXI's Roe CMXI's Valuation Ratios CMXI's Financial Strength Ratios CMXI's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Glucotrack Inc   843.28 %
Stablecoin Development Corporation  618.18 %
Omeros Corporation  198.34 %
Elutia Inc   191.75 %
Sanuwave Health Inc   167.92 %
Vor Biopharma Inc   162.71 %
Capforce Inc   161.42 %
Kyntra Bio Inc   157.74 %
Silexion Therapeutics Corp  127.60 %
Quince Therapeutics Inc   112.49 %
Pulmatrix Inc   108.83 %
Interpace Biosciences Inc   100.71 %


Date modified: 2026-09-08T17:09:12+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.